Entact Bio Appoints Michael Gutch, Ph.D., as Chief Operating Officer
Key Highlights Michael Gutch, Ph.D., joins as Chief Operating Officer Over two decades of life sciences industry experience…
Browsing Tag
AstraZeneca
20 posts
Nabla Bio Secures $26M in Series A Funding Round
Key Highlights $26 million Series A financing led by Radical Ventures, with full participation from existing investors. Strategic collaborations…
Reginald Seeto Appointed CEO of Scipher Medicine
Key Highlights Reginald Seeto, MBBS, appointed as CEO and President of Scipher Medicine. Scipher’s SpectraTM platform powers advancements in autoimmune diagnostics…
Jo Goodman Joins Celerion as VP of Bioanalytical Services
Key Highlights Jo Goodman appointed as VP of Bioanalytical Services at Celerion’s Lincoln, Nebraska laboratory. Goodman brings over 29 years…
Asher Bio Secures $55M in Series C Funding for Cancer Therapy
Key Highlights $55 million raised in Series C financing to advance AB248, a novel cancer immunotherapy. New investors include AstraZeneca…
GRAIL Teams with AstraZeneca for Cancer Test in Japan
Key Highlights GRAIL’s novel risk classification test on its Methylation Platform extends to Japan, in collaboration with AstraZeneca. The…
AstraZeneca’s $300M Investment in Rockville’s Cell Therapy Facility
Key Highlights $300 million investment in a state-of-the-art cell therapy facility in Rockville, MD. The site will create over 150…
Deborah Autor Appointed as CEO of Healthcare Innovation Catalysts
Key Highlights Deborah M. Autor joins Healthcare Innovation Catalysts, Inc. (HIC) as its first Chief Executive Officer, bringing over 30…
AstraZeneca to Acquire Gracell Biotechnologies to Boost Cell Therapy Portfolio
Key Highlights AstraZeneca announces definitive agreement to acquire Gracell Biotechnologies, enhancing its cell therapy ambitions with novel CAR-T treatments.…
AstraZeneca’s Strategic Acquisition of Icosavax: Pioneering the Future of Respiratory Vaccine Development
Key Highlights AstraZeneca acquires Icosavax, Inc., enhancing its position in respiratory vaccine development with the promising IVX-A12 vaccine.…